Abstract:Cardiovascular diseases (CVDs) are a class of disorders affecting the heart or blood vessels. Despite progress in clinical research and therapy, CVDs still represent the leading cause of mortality and morbidity worldwide. The hallmarks of cardiac diseases include heart dysfunction and cardiomyocyte death, inflammation, fibrosis, scar tissue, hyperplasia, hypertrophy, and abnormal ventricular remodeling. The loss of cardiomyocytes is an irreversible process that leads to fibrosis and scar formation, which, in turn, induce heart failure with progressive and dramatic consequences. Both genetic and environmental factors pathologically contribute to the development of CVDs, but the precise causes that trigger cardiac diseases and their progression are still largely unknown. The lack of reliable human model systems for such diseases has hampered the unraveling of the underlying molecular mechanisms and cellular processes involved in heart diseases at their initial stage and during their progression. Over the past decade, significant scientific advances in the field of stem cell biology have literally revolutionized the study of human disease in vitro. Remarkably, the possibility to generate disease-relevant cell types from induced pluripotent stem cells (iPSCs) has developed into an unprecedented and powerful opportunity to achieve the long-standing ambition to investigate human diseases at a cellular level, uncovering their molecular mechanisms, and finally to translate bench discoveries into potential new therapeutic strategies. This review provides an update on previous and current research in the field of iPSC-driven cardiovascular disease modeling, with the aim of underlining the potential of stem-cell biology-based approaches in the elucidation of the pathophysiology of these life-threatening diseases.

Endothelial dysfunction and cardiovascular diseases: The role of human induced pluripotent stem cells and tissue engineering

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Applications, challenges, and prospects of induced pluripotent stem cells for vascular disease

Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure

Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges

Advances in the differentiation of pluripotent stem cells into vascular cells

Induced pluripotent stem cells and cardiovascular disease

Potential Applications Of Induced Pluripotent Stem Cells For Cardiovascular Diseases

Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives

Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy

Endothelial Dysfunction and the Role of iPSC-Derived Endothelial Cells in Disease Modeling

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease

Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

Stem Cells for Tissue Engineering of Myocardial Constructs

Cells And Vascular Tissue Engineering

The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing

Applications of Induced Pluripotent Stem Cells (IPS) in the Study of Cardiovascular Disease

Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery

Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy